CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS
· Delayed Price · Currency is USD
0.107
-0.006 (-5.56%)
At close: Dec 5, 2025
CERO Market Cap
CERO has a market cap or net worth of $2.25 million as of December 5, 2025. Its market cap has decreased by -93.75% in one year.
Market Cap
2.25M
Enterprise Value
9.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since November 30, 2021, CERO's market cap has decreased from 222.99M to 2.25M, a decrease of -98.99%. That is a compound annual growth rate of -68.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 2.38M | -79.29% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 298.99M |
| Nika Pharmaceuticals | 259.91M |